|
|
||||||||
Journal of Lipid Research, Vol 26, 1089-1101, Copyright © 1985 by Lipid Research, Inc.
EJ Schaefer, JM Ordovas, SW Law, G Ghiselli, ML Kashyap, LS Srivastava, WH Heaton, JJ Albers, WE Connor and FT Lindgren
The biochemical, clinical, and genetic features were examined in the
proband (homozygote) and heterozygotes (n = 17) affected with familial
apolipoprotein A-I and C-III deficiency, variant II (previously described
as apolipoprotein A-I absence). The proband was a 45-year-old white female
with mild corneal opacification and significant three- vessel coronary
artery disease (CAD), who died shortly after bypass surgery. Autopsy
findings included significant atherosclerosis in the coronary and pulmonary
arteries and the abdominal aorta as well as extracellular stromal lipid
deposition in the cornea. No reticuloendothelial lipid deposits in the
liver, bone marrow, or spleen were noted (unlike Tangier disease).
Laboratory features included marked high density lipoprotein (HDL)
deficiency and undetectable plasma apolipoproteins (apo) A-I and C-III. The
percentage of plasma cholesterol in the unesterified form was normal at
30%. The activity and mass of lecithin:cholesterol acyltransferase (LCAT)
were 42% and 36% of normal, respectively, and the cholesterol
esterification rate was 43% of normal. Deficiencies of plasma vitamin E and
essential fatty acid (linoleic, C18:2) were also noted. Evaluation of
plasma lipoproteins and apolipoproteins in 37 kindred members revealed 17
heterozygotes with HDL cholesterol values below the 10th percentile of
normal. Of these, all had apoA-I levels more than one standard deviation
below the normal mean, and 37.5% had a similar decrease in apoC-III values.
Mean (+/- SD) plasma HDL cholesterol, apoA-I, and apoC- III values (mg/dl)
in heterozygotes were 54.0%, 62.4%, and 79.2% of normal, respectively. No
evidence of CAD was observed in 10 heterozygotes 40 years of age or less;
however, CAD was detected in 3 of 7 heterozygotes over 40 years of age, one
of whom died at age 56 years of complications of myocardial infarction and
stroke. The inheritance pattern in this kindred was autosomal codominant.
ApoA-I isolated from a heterozygote had an isoelectric focusing pattern and
amino acid composition similar to normal. Utilizing DNA isolated from two
obligate heterozygotes, no abnormalities in the apoA-I or apoC-III genes
were detected by Southern blot analysis utilizing specific probes following
restriction enzyme digestion. The data indicate that familial
apolipoprotein A-I and C-III deficiency, variant II, is similar to variant
I (described by Norum et al. 1982. N. Engl. J. Med. 306: 1513- 1519), but
differs at the clinical level (lack of xanthomas), the biochemical level
(lack of detectable apoA-I, lower apoA-II level), and at the gene
level.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Familial apolipoprotein A-I and C-III deficiency, variant II
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency J. Lipid Res., February 1, 2008; 49(2): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Jong, M. H. Hofker, and L. M. Havekes Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 472 - 484. [Full Text] [PDF] |
||||
![]() |
K. Moriyama, J. Sasaki, Y. Takada, A. Matsunaga, J. Fukui, J. J. Albers, and K. Arakawa A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1416 - 1423. [Abstract] [Full Text] |
||||
![]() |
D. S. Ng, C. Vezina, T. S. Wolever, A. Kuksis, R. A. Hegele, and P. W. Connelly Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2157 - 2164. [Abstract] [Full Text] |
||||
![]() |
K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1866 - 1874. [Abstract] [Full Text] |
||||
![]() |
M. Marcil, B. Boucher, L. Krimbou, B. C. Solymoss, J. Davignon, J. Frohlich, and J. Genest Jr Severe Familial HDL Deficiency in French-Canadian Kindreds : Clinical, Biochemical, and Molecular Characterization Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1015 - 1024. [Abstract] [Full Text] |
||||
![]() |
R. Prioli, J. Ordovas, I Rosenberg, E. Schaefer, and M. Pereira Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein Science, December 4, 1987; 238(4832): 1417 - 1419. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |